Smartphone-based optical scanner to physiologically assess diabetic foot ulcers
Project Number5R01EB033413-03
Contact PI/Project LeaderGODAVARTY, ANURADHA
Awardee OrganizationFLORIDA INTERNATIONAL UNIVERSITY
Description
Abstract Text
PROJECT SUMMARY
One in three people with diabetes mellitus is at risk of diabetic foot ulcers (DFUs), with over 10% amputated.
The current global pandemic has driven a significant change in healthcare delivery and disrupted DFU care and
limb preservation, leaving many patients with limited or no clinical care.
Clinicians must adopt a paradigm shift
from the hospital and clinic care to community-based point-of-care (POC) - to best triage chronic DFU cases that
are high-risk lesions requiring clinical care or hospitalization. There is an unmet clinical need for smart health
assessment tools for POC treatment of patients with DFUs onsite, where no wound care expertise is available.
Smartphone technologies for wound care are limited to 2D/3D wound image analysis for size/depth. They are
insufficient as stand-alone tools to assess and triage high-risk DFU lesions without wound expertise onsite.
Hence, additional clinical assessments (e.g., the extent of oxygen supply to wound) are required during POC of
DFUs onsite.
Oxygenation measurements provide a sub-clinical physiological assessment that complements
clinical visual assessment. We recently developed a smartphone-based NIR imaging approach or SmartPhone
Oxygenation Tool (SPOT) to obtain visual tissue oxygenation measurements in wounds. Systematic
assessment of the skin tone and wound characteristics is critical during physiological imaging and has not been
investigated to date. Hence, our objective is to develop and validate a smartphone-based imaging approach
(or Smart Scanner) capable of visual and physiological analysis of DFUs across the spectrum of skin tones and
wound features via automated machine learning (ML) algorithms. Developing a smartphone-based optical device
via integration of existing NIR imaging technology, but towards smart health platform for physiological
assessment of DFUs, while accounting for varying skin colors and wound types using ML algorithms is
innovative. The specific aims are: (i) Account for the effect of skin tones on oxygenation measurements by
applying light propagation models and machine learning algorithms and validate via phantom and in-vivo studies.
(ii) Analyze tissue curvatures and account for depth variations in-vivo oxygenation maps via studies on control
subjects (~15 cases). (iii) Differentiate wound tissue types and validate physiological imaging using the SPOT
device via DFU studies (~25 cases). The expected outcomes are: (i) Develop our Smart Scanner (SPOT
device + app) to obtain accurate tissue oxygenation maps across different skin tones and wound tissue types;
(ii) Validate our SPOT device to differentiate DFUs with high-risk lesions that require clinical care, from low-risk
cases. Incidence of DFUs and related amputation rates differ by race/ethnicity, and are higher in African
Americans, Hispanic and Native Americans compared to Caucasians. In the long term, SPOT can be used as
a smart health tool to pre-screen or triage DFUs with high-risk lesions to clinical care and thus minimize potential
amputations in any racial/ethnic group (with varying skin tones).
Public Health Relevance Statement
PROJECT NARRATIVE
Assessing wounds from a subclinical physiological perspective is a novel addition to smartphone-based
technologies that augment mobile health (mHealth) point-of-care wound management, potentially predicting
serious complications early on, and triage diabetic foot ulcers (DFUs) with high-risk lesions for clinical care. In
addition, the development and validation of a smartphone-based optical device that performs physiological
imaging (based on oxygen to wounds) apart from visual imaging across any skin tone and foot curvatures make
the technology applicable across different racial/ethnic groups.
NIH Spending Category
No NIH Spending Category available.
Project Terms
3-DimensionalAdoptedAfrican American populationAmputationAssessment toolBeerCaringCaucasiansCellular PhoneCharacteristicsChronicChronic CareClinicalClinical assessmentsClinics and HospitalsCollaborationsCommunitiesComplications of Diabetes MellitusDevelopmentDevicesDiabetes MellitusDiabetic Foot UlcerDiscipline of NursingEthnic OriginEthnic PopulationExcisionFloridaFunctional ImagingHispanic AmericansHospitalizationImageImage AnalysisImaging technologyIncidenceInternationalLawsLesionLightLimb structureMapsMeasurementModelingNative AmericansNear-infrared optical imagingNoiseOpticsOutcomeOxygenPatientsPersonsPhysiologicalPigmentation physiologic functionPositioning AttributeRaceResearchResearch DesignRiskSMART healthSigns and SymptomsSiteSkinSurfaceSurgeonTechnologyTissuesTriageValidationVariantVisualclinical carecomputer scienceflufootglobal healthhealinghealth care deliveryhigh riskimaging approachin vivoinnovationmHealthmachine learning algorithmmultidisciplinarymutantnovelpandemic diseasepoint of carepreservationracial populationskin colorskin woundstatisticstissue mappingtissue oxygenationtissue phantomtoolvalidation studieswoundwound carewound treatment
National Institute of Biomedical Imaging and Bioengineering
CFDA Code
286
DUNS Number
071298814
UEI
Q3KCVK5S9CP1
Project Start Date
15-August-2022
Project End Date
31-May-2026
Budget Start Date
01-June-2024
Budget End Date
31-May-2025
Project Funding Information for 2024
Total Funding
$531,790
Direct Costs
$400,632
Indirect Costs
$131,158
Year
Funding IC
FY Total Cost by IC
2024
National Institute of Biomedical Imaging and Bioengineering
$531,790
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R01EB033413-03
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01EB033413-03
Patents
No Patents information available for 5R01EB033413-03
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01EB033413-03
Clinical Studies
No Clinical Studies information available for 5R01EB033413-03
News and More
Related News Releases
No news release information available for 5R01EB033413-03
History
No Historical information available for 5R01EB033413-03
Similar Projects
No Similar Projects information available for 5R01EB033413-03